Navigation Links
Irvine Pharmaceutical Services Introduces New Fill-and-Finish Subsidiary
Date:11/11/2008

IRVINE, Calif., Nov. 11 /PRNewswire/ -- Irvine Pharmaceutical Services, Inc., today announced the forthcoming January 2009 launch of Avrio Biopharmaceuticals. This venture is part of Irvine's overall growth strategy focused on improving its services and product offerings to current and potential clients.

Outfitted with an experienced team and state of the art equipment, Avrio Biopharma will provide a full range of formulation development and aseptic fill-and-finish services. It will be focused on developing optimized production processes and providing dependable filling, lyophilization and packaging capabilities for early phase clinical trial materials.

"We are very excited about this extension of our company," said Assad J. Kazeminy, CEO and Founder of Irvine Pharmaceutical Services. "Avrio will help round out our existing capabilities and its connection to Irvine will also make it possible to provide our clients with broader services via seamless partnership."

Since early 2007, Irvine Pharmaceutical Services, Inc., has experienced extensive growth and has made significant upgrades in its lab equipment and infrastructure. The opening of Avrio Biopharma is yet another step along the same growth lines, striving to better serve the needs of the company's clients and the pharmaceutical industry.

You can meet the team and learn more about Irvine and its new company, Avrio, at the AAPS Annual Meeting, booth 1707.

About Irvine

Irvine Pharmaceutical Services, Inc. is a fully integrated services provider that works with pharmaceutical, biotechnology and medical device companies through all phases of research and development. Founded in 1988 and committed to expansion and services that benefit its clients' priorities directly, Irvine is a fully cGMP compliant contract testing laboratory located in Irvine, CA. Visit http://www.irvinepharma.com or call (877) 445-6554. '/>"/>

SOURCE Irvine Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion
2. Hoag Hospital Announces Agreement to Open Irvine Campus
3. Lucas Group to Host Military Hiring Conferences in Washington, DC; Irvine, CA and Dallas, TX
4. UC Irvine to lead statewide program on green materials research
5. UC Irvine researchers present latest findings at emergency medicine forum
6. UC-Irvine scientists present groundbreaking research at Society for Neuroscience conference
7. KV Pharmaceutical to File Form 12b-25 on November 12, 2008
8. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
10. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
11. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...d was too short to draw definite conclusions, expe...Day News) -- In diabetic patients with blocked cor...in outcomes at one year whether patients undergo b...h researchers report. , Bypass surgery has been... coronary artery disease. However, less invasive a...
(Date:11/25/2009)... Evaluation and treatment clinics to resume Monday...cus) November 25, 2009 -- Centegra Health System i... vaccine shots at four Centegra Primary Care (CPC)...cine has arrived. The clinics are at CPC sites in ...ill be open as follows: ,   From 4:30 ...
(Date:11/25/2009)...y neurological symptoms, study finds , ,...cal side effects are among the potential problems ...who were treated with cisplatin-based chemotherapy...,409 Norwegian men treated for unilateral testicul... follow-up survey conducted from 1998 to 2002. ,...
(Date:11/25/2009)...Newswire/-- MISSIONSkincare ®isproudtosupport...artofGNC,sannualSt.Jude ThanksandGiving campaign,$...w SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Addit...or$10donationatcheckoutatoneoftheir5,000+retailloc...forSt.Judeduringtheir2009 ThanksandGiving campaign...
(Date:11/25/2009)...ntShownforthe4thStraightYear ,, WASHINGTON,No...iance-Georgia(LCA-GA)issuedthe 4thAnnualReportCard...ingmadeagainstthislethaldiseaseinthestateofGeorgia...nationalorganizationdedicatedexclusivelytopatients...gcancer. ,, (Logo: http://www.newscom.com/cgi-b...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...with dieting and weight loss failure turned to an ...ore than 75 lbs. over a 4 month period.// The...articipants to lose over 75 lbs, exercise more tha...rough WeightLossWars.com to her family and friends...
...other strikes India. The new demon is anthrax that...eath of a cow which was found to be infected with ...in Menderda taluka. A gigantic drive to vacc...r dead cow, and inform authorities if they suspect...
...med to score less in nutrition value because of hi...// like iron and protein. Sales of organic baby fo... are growing up on daily helpings of these foods. ...ntained three times more sugar as compared to pres...
...ustice Cyriac Joseph has expressed the need for qu...the government must not leave any stone unturned t... to the Chief Justice, this is a matter of grave c... the medical education field should take stock to ...
...s been criticized by Lancet, one of the world's le...dismissal of the editor (Dr. John Hoey) and deputy... Association Journal. The Lancet editors, in the l...h which they perform an important watchdog functio...
...he Rochester, Minnesota, medical college, whose re... days on treadmills or indoor tracks, walking as t... hold meetings. Researchers at the Mayo clinic sai...l journals. Levine said that this would save time,...
Other Medicine News:
(Date:11/25/2009)...ordingtoMillenniumResearchGroup(MRG),theglobalauth...ly$3billionUSmarketfortraumafixationdeviceswillcon...erecenteconomicslowdown.MRG,s USMarketsforTraumaDe...hlydynamicoverthenextfiveyears,withcompetitorsintr...gmentsofthetraumafixationmarket,fuelingmarketgrowt...
(Date:11/25/2009)...empraPharmaceuticalsInc.todayannouncedthatPrabhava...lpresentatthePiperJaffray21stAnnualHealthCareConfe...ceHotelinNewYorkCity.Dr.Fernandeswillprovideanover...ramsforthetreatmentofdrug-resistantpathogensinclud...Foundedin2006,CempraPharmaceuticalsisaprivately-he...
(Date:11/25/2009)...ker.comannouncesthatanewmarketresearchreportisavai...-USMarketTrends&Analysis http://www.reportlin...ket-Trends--Analysis.html ,, TheUSintranasaldr...icapplicationsfromthedeliveryofconventionallocalth...ugs.Thefutureofthetechnologyhingesontotheeffective...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 1Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 3H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 1H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 1Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 3
...uced risk of death by 13% (P=0.08), despite inclus...mara therapy , , - In a separate censored ana...o Femara, reduction in risk of death was 19% , ...IG 1-98 trial reinforces starting with Femara as t... , EAST HANOVER, N.J., Dec. 11 New long-term d...
...cember 11 AFFiRiS has started,pre-clinical develo... as,PD01, can be used to target a specific protein...s degenerative neurological disease. Excellent pro...ed the company to file a patent,application and pr...tive,results from external assessments impelled th...
Other Medicine Technology:Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 2Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 3Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 5Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 6Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 7Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 8AFFiRiS Begins Development of a Parkinson's Vaccine 2AFFiRiS Begins Development of a Parkinson's Vaccine 3
Sterile Coil Packed Pediatric Suction Catheters with SAFE-T-VAC Valve
Sterile Suction Catheters without Control Valve
Sterile Single Loop Suction Catheters with TOUCH-TROL Valve
Catheter Suction 14FR Sterile W/Control Valve
Medicine Products: